IL13 and asthma: After 6 mounts therapy with combination of ICS/LABA in patients with uncontrolled severe persistent asthma we found decreases of serum IL-13, but added the Montelukast in this combination proved superior effect and allow achievement of total control of asthma with subjective clinical improvement.